Quick Answer
Zhengye Biotechnology Holding Ltd reported Operating Income of $16.44 million for fiscal year 2024.
Zhengye Biotechnology Holding Ltd Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | $16.44M | -63.5% |
| 2023 | $44.99M | -31.7% |
| 2022 | $65.83M | — |
- Zhengye Biotechnology Holding Ltd showed a decrease of -63.5% in Operating Income compared to the prior fiscal year.
- Over the 2022–2024 period, Zhengye Biotechnology Holding Ltd’s operating income has declined by 75.0% (from $65.83 million to $16.44 million).
- The most recent figure is from Zhengye Biotechnology Holding Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on July 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: